Cancer is the highest single risk factor for thrombosis.

It is estimated that up to 20% of patients with cancer experience venous thrombosis (VTE).

There is a fivefold higher annual incidence of thrombosis among cancer patients, with about 1 in 1,000 in the general population and 1 in 200 in cancer patients.

Read the All Party Parliamentary Group for Thrombosis report: Cancer, Chemotherapy & Clots, October 2016 [PDF]

Warwick Clinical Trials Unit – selected Cancer associated thrombosis – a patient perspective

Cancer-associated thrombosis awareness survey - Results report - October 2018

European Cancer Patient Coalition
With support from LEO Pharma
Carried out by Quality Health Limited

Download Paper

Setting The scene – the global burden of CAT

Presented by: Lord Kakkar

Clinical decision-making and the role of patient choice

Presented by: Dr Simon Noble

Incidental VTE: Who should we anticoagulate?

Presented by: Dr Anthony Maraveyas


Presented by: Dr Ander Cohen

Anticoagulation for non-valvular AF during chemotherapy

Presented by: Dr Malcolm Walker

Cancer-associated thrombosis: 6 months and beyond

Presented by: Dr Vickie McDonald

Management of CAT - where data is lacking

Presented by: Dr Tim Nokes

IVC filters in CAT management

Presented by: Dr Maeve Crowley